Celularity Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Celularity
CELU Stock  USD 1.28  0.11  9.40%   
Analyzing historical trends in various income statement and balance sheet accounts from Celularity's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celularity's valuation are summarized below:
Gross Profit
20.5 M
Profit Margin
(1.99)
Market Capitalization
34.6 M
Enterprise Value Revenue
2.5164
Revenue
40.6 M
There are currently one hundred twenty fundamental signals for Celularity that can be evaluated and compared over time across rivals. All traders should validate Celularity's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 226.5 M in 2026, whereas Market Cap is likely to drop slightly above 49.7 M in 2026.

Celularity Total Revenue

65.47 Million

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 7.6 M or Total Revenue of 65.5 M, as well as many indicators such as Price To Sales Ratio of 0.92, Dividend Yield of 0.0 or PTB Ratio of 4.87. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Build AI portfolio with Celularity Stock
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets233.6 M119.4 M141 M
Slightly volatile
Short and Long Term Debt Total41.1 M79.2 M24.4 M
Slightly volatile
Total Current Liabilities40.3 M61.7 M21.2 M
Slightly volatile
Other Liabilities95.8 M100.9 M260 M
Slightly volatile
Property Plant And Equipment Net77.2 M83.3 M40.2 M
Slightly volatile
Accounts Payable28.1 M26.8 M9.4 M
Slightly volatile
Cash631 K664.2 K8 M
Pretty Stable
Non Current Assets Total95.9 M100.9 M400.6 M
Slightly volatile
Cash And Short Term Investments631 K664.2 K8 M
Pretty Stable
Net Receivables16.4 M15.6 M6.6 M
Slightly volatile
Good Will6.3 M6.6 M99.8 M
Slightly volatile
Common Stock Total Equity201.1 M313.9 M126.8 M
Slightly volatile
Common Stock Shares Outstanding26.4 M25.2 M8.9 M
Slightly volatile
Liabilities And Stockholders Equity145 M152.6 M137.1 M
Slightly volatile
Inventory5.8 M6.2 M4.5 M
Slightly volatile
Other Current Assets732.7 K771.3 K2.7 M
Pretty Stable
Total Liabilities176 M111.5 M107.6 M
Slightly volatile
Total Current Assets25.2 M18.5 M15.5 M
Slightly volatile
Intangible Assets7.9 M8.3 M248.3 M
Slightly volatile
Common Stock2.2 K2.3 K2.7 K
Slightly volatile
Property Plant Equipment69.1 M104.2 M42.8 M
Slightly volatile
Warrants193.9 M188.2 M246.1 M
Slightly volatile
Non Current Liabilities Total60 M63.1 M274.9 M
Slightly volatile
Capital Surpluse28 M55.6 M20.6 M
Slightly volatile
Non Current Liabilities Other1.4 M1.5 M31.1 M
Pretty Stable
Current Deferred Revenue2.6 M3.2 M4.3 M
Slightly volatile
Capital Lease Obligations22.8 M23.9 M29.2 M
Slightly volatile
Deferred Long Term Liabilities482542591
Slightly volatile
Property Plant And Equipment Gross115.1 M121.1 M101.8 M
Slightly volatile
Capital Stock2.2 K2.3 K3.7 K
Slightly volatile
Short Term Debt13.8 M7.3 M6.3 M
Slightly volatile
Short and Long Term Debt5.4 M5.7 M32.1 M
Slightly volatile
Long Term Debt28.7 M32.3 M35.3 M
Slightly volatile

Celularity Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization8.3 M9.1 M6.4 M
Slightly volatile
Total Revenue65.5 M62.4 M25.7 M
Slightly volatile
Other Operating Expenses95.7 M83.3 M58.2 M
Slightly volatile
Research Development14.9 M15.6 M35.6 M
Pretty Stable
Cost Of Revenue12.3 M17.2 M9.4 M
Slightly volatile
Total Operating Expenses87.1 M69.8 M54 M
Slightly volatile
Selling General Administrative58.2 M67.4 M47.6 M
Slightly volatile
Selling And Marketing Expenses19.7 K20.7 K755.6 K
Slightly volatile
Interest Income274.9 K297.9 K352.4 K
Slightly volatile
Reconciled Depreciation9.6 M9.1 M8.5 M
Slightly volatile

Celularity Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation14.9 M13.3 M9.4 M
Slightly volatile
Begin Period Cash Flow11.1 M11.7 M29.9 M
Pretty Stable
Depreciation8.6 M9.1 M6.5 M
Slightly volatile
Capital Expenditures137.7 K144.9 K3.6 M
Very volatile
Total Cash From Financing Activities5.7 M6 M38.4 M
Pretty Stable
End Period Cash Flow12 M12.6 M11.6 M
Slightly volatile
Other Cashflows From Investing Activities2.5 M2 M1.5 M
Slightly volatile
Issuance Of Capital Stock5.1 M5.4 M75.7 M
Slightly volatile
Dividends Paid31.3 M35.2 M38.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.920.9713.9285
Slightly volatile
Days Sales Outstanding93.5482.1496.8307
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue0.230.250.4135
Slightly volatile
Capex To Depreciation0.02220.02340.7112
Very volatile
EV To Sales2.292.4114.3943
Slightly volatile
Inventory Turnover1.752.492.0254
Slightly volatile
Days Of Inventory On Hand219151196
Pretty Stable
Payables Turnover0.70.7420.862
Very volatile
Sales General And Administrative To Revenue2.441.242.1874
Pretty Stable
Research And Ddevelopement To Revenue0.350.371.8617
Very volatile
Capex To Revenue0.00320.00340.2178
Very volatile
Cash Per Share0.03680.03882.8239
Pretty Stable
Days Payables Outstanding536511320
Slightly volatile
Intangibles To Total Assets0.140.125111.2 K
Slightly volatile
Current Ratio0.420.440.6056
Slightly volatile
Receivables Turnover4.094.64.1523
Slightly volatile
Capex Per Share0.0080.00851.2627
Very volatile
Revenue Per Share4.682.854.4896
Slightly volatile
Interest Debt Per Share7.353.953.4366
Slightly volatile
Debt To Assets1.170.63.3969
Slightly volatile
Graham Number14.4116.2117.6952
Slightly volatile
Operating Cycle347256296
Pretty Stable
Days Of Payables Outstanding536511320
Slightly volatile
Long Term Debt To Capitalization0.640.720.7882
Slightly volatile
Total Debt To Capitalization1.411.023.5942
Slightly volatile
Net Income Per E B T0.760.90.8555
Slightly volatile
Cash Ratio0.0150.01580.3864
Pretty Stable
Days Of Inventory Outstanding219151196
Pretty Stable
Days Of Sales Outstanding93.5482.1496.8307
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.181.9 K
Slightly volatile
Fixed Asset Turnover0.990.862.5406
Slightly volatile
Debt Ratio1.170.63.3969
Slightly volatile
Price Sales Ratio0.920.9713.9285
Slightly volatile
Asset Turnover0.450.47376
Slightly volatile

Celularity Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap49.7 M52.4 M202 M
Slightly volatile
Enterprise Value226.5 M130.7 M227.1 M
Slightly volatile

Celularity Fundamental Market Drivers

Celularity Upcoming Events

2nd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.2 M2.6 M
Total Revenue62.4 M65.5 M
Cost Of Revenue17.2 M12.3 M
Stock Based Compensation To Revenue 0.25  0.23 
Sales General And Administrative To Revenue 1.24  2.44 
Research And Ddevelopement To Revenue 0.37  0.35 
Revenue Per Share 2.85  4.68 
Ebit Per Revenue(0.64)(0.67)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY